Severity of Lesions Assessed by FFR in Coronary Disease: Is It Associated with Major Events?

severity of lesions ffrIn patients with coronary disease, the prognosis depends on the extent and reversibility of myocardial ischemia. Whether the outcome also depends on the severity of stenosis as determined by fractional flow reserve (FFR) has not been studied yet.

 

This study investigates the relationship between fractional flow reserve values and vessel-related events. Major adverse cardiovascular events (MACE) at 2 years were prospectively studied in 607 patients in whom all stenoses were assessed by FFR and who received medical therapy only.

 

Moreover, logistic regression models were used to calculate the decrease in the risk per 0.05 increase in FFR values.

 

Events were present for 272 (26.5%) of 1029 lesions. Lesions with stenosis diameter ≥70% were more often present in the group experiencing events (p <0.01).

 

The mean fractional flow reserve value was significantly lower in the group experiencing events than in the group with no events (0.68 vs. 0.80; p <0.01).

 

The cumulative incidence of MACE significantly increases with increasing FFR quartiles.

 

The average decrease in MACE per 0.05 increase in FFR was statistically significant, even after adjustment for all clinical and angiographic variables. The strongest increase in adverse events occurred for FFR values between 0.80 and 0.60. In a multivariate analysis, FFR was significantly associated with events at 2 years

 

Conclusion

In patients with stable coronary disease, functional severity of a lesion as assessed by fractional flow reserve is independently associated with major cardiovascular events.

 

Original title: A Prospective Natural History Study of Coronary Atherosclerosis Using Fractional Flow Reserve.

Reference: Emanuele Barbato et al. J Am Coll Cardiol. 2016;68(21):2247-2255.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...

Rolling Stone: Registry of Intravascular Lithotripsy vs Atherectomy Use in Complex Calcified Lesions

Severe coronary calcification represents one of the main challenges in performing percutaneous coronary intervention, both due to the higher risk of stent underexpansion and...

Morpheus Global Registry: Safety and efficacy of the long tapered BioMime™ Morph stent in complex coronary lesions

Percutaneous coronary intervention in long coronary lesions continues to represent a technical and clinical challenge, in which the use of conventional cylindrical stents may...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Low-Dose Rivaroxaban After Peripheral Angioplasty: Effectiveness and Safety in Real-World Clinical Practice

Following lower limb revascularization, optimal medical therapy includes antiplatelet agents, high-intensity statins, and control of cardiovascular risk factors. Recent studies such as COMPASS and...

Sheathless Femoral Impella: A New Strategy to Reduce Vascular Complications in High-Risk PCI?

Patients with complex coronary artery disease or cardiogenic shock undergoing percutaneous coronary intervention (PCI) may benefit from the hemodynamic support provided by percutaneous ventricular...

OCT- and IVUS-Guided Coronary Angioplasty in Acute Coronary Syndrome: Long-Term Clinical Outcomes

Percutaneous coronary angioplasty (PCI) in patients with acute coronary syndrome (ACS) has reduced mortality in the acute phase. However, recurrent ACS and target vessel...